Background Although several COVID-19 vaccines have been developed so far, they will not
be sufficient to meet the global demand. Development of a wider range of vaccines, with …

Vaccines are urgently needed to control the ongoing pandemic COVID-19 and previously
emerging MERS/SARS caused by coronavirus (CoV) infections. The CoV spike receptor-…

Safe, efficacious, and deployable vaccines are urgently needed to control COVID-19 in the
large-scale vaccination campaigns. We report here the preclinical studies of an approved …

Rapid and accurate identification of respiratory tract infection pathogens is of utmost importance
for clinical diagnosis and treatment, as well as prevention of pathogen transmission. To …

The application of conventional chemiluminescence immunoassay (CLIA) in resource-limited
settings is limited due to the large apparatus footprint, cumbersome operation and …

ZF2001, a protein subunit vaccine against coronavirus disease 2019 (COVID-19), contains
recombinant tandem repeat of dimeric receptor-binding domain (RBD) protein of the SARS-…

Background A safe and effective coronavirus disease 2019 (COVID-19) vaccine is urgently
needed to control the ongoing pandemic. Although progress has been made recently with …

Despite the advantages of digital nucleic acid analysis (DNAA) in terms of sensitivity,
precision, and resolution, current DNAA methods commonly suffer a limitation in multiplexing …

Rapid screening of infectious pathogens at the point-of-care (POC) is ideally low-cost, portable,
easy to use, and capable of multiplex detection with high sensitivity. However, satisfying …

Although the new coronavirus disease 2019 (COVID-19) outbreak occurred in late 2019, it
is still endemic worldwide, and has become a global public health problem. Vaccination …